进行性多灶性白质脑病的替代终点。

IF 46.5 1区医学 Q1 CLINICAL NEUROLOGY

Lancet Neurology Pub Date : 2024-05-01 DOI:10.1016/S1474-4422(24)00132-7

Joep Killestein, Mike P Wattjes

引用次数: 0

摘要

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Surrogate endpoints for progressive multifocal leukoencephalopathy.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Lancet Neurology 医学-临床神经学

CiteScore

58.70

自引率

1.00%

发文量

572

审稿时长

6-12 weeks

期刊介绍： The Lancet Neurology is the world-leading clinical neurology journal. It publishes original research that advocates for change in, or sheds light on, neurological clinical practice. The topics covered include cerebrovascular disease, Alzheimer's disease and other dementias, epilepsy, migraine, neurological infections, movement disorders, multiple sclerosis, neuromuscular disorders, peripheral nerve disorders, pediatric neurology, sleep disorders, and traumatic brain injury. The journal publishes a range of article types, including Articles (including randomized clinical trials and meta-analyses), Review, Rapid Review, Comment, Correspondence, and Personal View. It also publishes Series and Commissions that aim to shape and drive positive change in clinical practice and health policy in areas of need in neurology. The Lancet Neurology is an internationally trusted source of clinical, public health, and global health knowledge. It has an Impact Factor of 48.0, making it the top-ranked clinical neurology journal out of 212 journals worldwide.